The effects of morning versus evening dose of hydroxyzine 50 mg on cognition in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 24 Mar 2012
At a glance
- Drugs Hydroxyzine (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 19 Apr 2011 Results published in the Journal of Clinical Psychopharmacology.
- 19 Apr 2011 Status changed from recruiting to completed, based on results published in the Journal of Clinical Psychopharmacology.
- 15 Jun 2009 New trial record